Boehringer Ingelheim buys Northern Biologics’ preclinical pipeline

Boehringer Ingelheim has acquired the preclinical cancer antibody pipeline of Northern Biologics, a Toronto-based therapeutic antibodies affiliate of Northern LP.

ByVCJ Staff

15 May 2020•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Canada North America Life Sciences Briefs

Boehringer Ingelheim buys Northern Biologics’ preclinical pipeline

Versant Ventures

Related articles